Article
Glutamatergic and HPA-axis pathway genes in bipolar disorder comorbid with alcohol- and substance use disorders.
Metabolic brain disease - 1 Feb 2016
Dalvie Shareefa, Fabbri Chiara, Ramesar Raj, Serretti Alessandro, Stein Dan J
Abstract excerpt
Glutamatergic neurotransmission has been shown to be dysregulated in bipolar disorder (BD), alcohol use disorder (AUD) and substance use disorder (SUD). Similarly, disruption in the hypothalamic-pituitary-adrenal (HPA)-axis has also been observed in these conditions. BD is often comorbid with AUD and SUD. The effects of the glutamatergic and HPA systems have not been extensively examined in individuals with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
